Stockreport

TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference

TScan Therapeutics, Inc.  (TCRX) 
PDF WALTHAM, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell [Read more]